NCT00567593View on ClinicalTrials.gov

Gene Regulation by Thiazolidinediones

PHASE4CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Inflammatory Bowel Disease
Interventions
DRUG

Rosiglitazone

8mg tablet once a day for 14 days

Trial Locations (1)

19104

University of Pennsylvania Clinical and Translational Research Center, Philadelphia

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

James Lewis

OTHER

NCT00567593 - Gene Regulation by Thiazolidinediones | Biotech Hunter | Biotech Hunter